Hauck R S, Nau H
Institute of Toxicology and Embryopharmacology, Free University Berlin, Germany.
Pharm Res. 1992 Jul;9(7):850-5. doi: 10.1023/a:1015832411981.
The teratogenic activities of R(+)- and S(-)-2-n-propyl-4-pentynoic acid (R and S-4-yn-VPA), the enantiomers of the highly teratogenic valproic acid (VPA) analogues (+/-)-4-yn-VPA, were investigated in mice. The enantiomers were prepared via asymmetric synthesis, each in three steps employing the chiral auxiliaries (4R,5S)-4-methyl-5-phenyl-2-oxazolidinone and S-4-benzyl-2-oxazolidinone. The determination of the absolute configurations and the optical purities is described. R(+)-4-yn-VPA contained 7%, and S(-)-4-yn-VPA 8%, of the respective antipodes. The aqueous solutions of the sodium salts of R- and S-4-yn-VPA were administered as single i.p. injections during early organogenesis in the mouse (day 8 of gestation) using the induction of exencephaly as the teratological end point. Dose/exencephaly curves indicated that S-4-yn-VPA is 7.5 times more teratogenic than its antipode, 1.9 times more teratogenic than (+/-)-4-yn-VPA and 3.9 times more teratogenic than the parent drug VPA. In contrast, the neurotoxicity (maternal toxicity) of the 4-yn-VPA enantiomers was found to be independent of the stereo-chemical configuration and lower than achieved after VPA administration. Due to its low neurotoxicity and highly stereoselective neural tube-inducing activity, S-4-yn-VPA should prove an important tool for the investigation of molecular mechanism of the teratogenic action in this class of compounds; R-4-yn-VPA could act as the negative control in these studies.
在小鼠中研究了高致畸性丙戊酸(VPA)类似物(±)-4-戊炔酸(4-yn-VPA)的对映体R(+)-和S(-)-2-正丙基-4-戊炔酸(R和S-4-yn-VPA)的致畸活性。通过不对称合成制备对映体,每个对映体分三步使用手性助剂(4R,5S)-4-甲基-5-苯基-2-恶唑烷酮和S-4-苄基-2-恶唑烷酮。描述了绝对构型和光学纯度的测定。R(+)-4-yn-VPA含有7%的相应对映体,S(-)-4-yn-VPA含有8%的相应对映体。以无脑儿的诱导作为致畸学终点,在小鼠器官发生早期(妊娠第8天),将R-和S-4-yn-VPA的钠盐水溶液作为单次腹腔注射给药。剂量/无脑儿曲线表明,S-4-yn-VPA的致畸性比其对映体高7.5倍,比(±)-4-yn-VPA高1.9倍,比母体药物VPA高3.9倍。相反,发现4-yn-VPA对映体的神经毒性(母体毒性)与立体化学构型无关,且低于VPA给药后的毒性。由于其低神经毒性和高度立体选择性的神经管诱导活性,S-4-yn-VPA应被证明是研究这类化合物致畸作用分子机制的重要工具;R-4-yn-VPA可作为这些研究中的阴性对照。